EXPERIENCE WITH THE USE OF EVOLOCUMAB THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (IN KARELIA REPUBLIC)
Aim: to evaluate the efficacy and safety of the use of evolocumab in patients with familial hypercholesterolemia (FH).Materials and methods: Fifteen patients with a definite FH were treated with PCSK9 inhibitors, in 11 patients with a history of CAD. Eight patients (53.3%) received evolocumab (Repat...
Main Authors: | , , |
---|---|
格式: | 文件 |
语言: | Russian |
出版: |
InterMedservice
2020-06-01
|
丛编: | Евразийский Кардиологический Журнал |
主题: | |
在线阅读: | https://www.heartj.asia/jour/article/view/6206 |